Trial intelligence / Profile preview

Tecovirimat in Non-hospitalized Patients With Monkeypox

NCT05534165Phase 3Suspended

Start
Aug 2023
Primary completion
Mar 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tecovirimat in mpox. Started Aug 2023; status: suspended.

02

Drugs

tecovirimat
03

Conditions

mpox

Beyond the preview

Go deeper on NCT05534165.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05534165.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call